Osaka, Japan

Yasuhiko Kawano



Average Co-Inventor Count = 2.3

ph-index = 4

Forward Citations = 35(Granted Patents)


Company Filing History:


Years Active: 2009-2015

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Yasuhiko Kawano: Innovator in Pharmaceutical Chemistry

Introduction

Yasuhiko Kawano is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds and methods for producing optically active substances. With a total of 4 patents to his name, Kawano's work has implications for various therapeutic applications.

Latest Patents

Kawano's latest patents include a method for producing optically active tetrahydroquinolines. This innovative method involves a novel chiral iridium(III) complex, which facilitates the production of optically active 2-substituted-1,2,3,4-tetrahydroquinolines from 2-substituted-quinolines. The process is designed to be more economical and easier than previous methods. Another significant patent involves a fused quinoline derivative that exhibits neurokinin 2 (NK2) receptor antagonistic action. This compound has potential therapeutic applications, showcasing Kawano's focus on creating valuable pharmaceutical agents.

Career Highlights

Throughout his career, Kawano has worked with prominent companies in the pharmaceutical industry, including Takeda Pharmaceutical Company Limited and Hamari Chemicals, Ltd. His experience in these organizations has allowed him to refine his expertise in drug development and innovation.

Collaborations

Kawano has collaborated with notable colleagues such as Masahiro Kajino and Sadayuki Maeda. These partnerships have contributed to his success in the field and have fostered a collaborative environment for innovation.

Conclusion

Yasuhiko Kawano's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the development of new therapeutic agents, showcasing the importance of innovation in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…